All Stories

  1. The antimycotic 5-fluorocytosine is a virulence inhibitor of uropathogenic Escherichia coli and eradicates biofilm-embedded bacteria synergizing with β-lactams
  2. From Traditional Medicine to the Laboratory: A Multidisciplinary Investigation on Agrimonia eupatoria L. Collected in Valle Imagna (BG, North of Italy)
  3. The antimycotic 5-fluorocytosine is a virulence inhibitor of uropathogenicEscherichia coliand eradicates biofilm-embedded bacteria synergizing with β-lactams
  4. Widespread alterations in systemic immune profile are linked to lung function heterogeneity and airway microbes in cystic fibrosis
  5. Fluoropyrimidines affect de novo pyrimidine synthesis impairing biofilm formation in Escherichia coli
  6. Clinical implications of innate immune exhaustion in cystic fibrosis
  7. Cystic fibrosis systemic immune profile is associated with lung microbes and characterized by widespread alterations in the innate and adaptive immune compartments
  8. Lack of Direct Correlation between Biofilm Formation and Antimicrobial Resistance in Clinical Staphylococcus epidermidis Isolates from an Italian Hospital
  9. Inactivation of the Pyrimidine Biosynthesis pyrD Gene Negatively Affects Biofilm Formation and Virulence Determinants in the Crohn’s Disease-Associated Adherent Invasive Escherichia coli LF82 Strain
  10. Editorial: Pseudomonas aeruginosa Pathogenesis: Virulence, Antibiotic Tolerance and Resistance, Stress Responses and Host-Pathogen Interactions
  11. Compensatory evolution of Pseudomonas aeruginosa’s slow growth phenotype suggests mechanisms of adaptation in cystic fibrosis
  12. Gut vascular barrier impairment leads to intestinal bacteria dissemination and colorectal cancer metastasis to liver
  13. Pseudomonas aeruginosa adaptation and evolution in patients with cystic fibrosis
  14. Filamentous bacteriophages are associated with chronic Pseudomonas lung infections and antibiotic resistance in cystic fibrosis
  15. Biofilm and motility in response to environmental and host-related signals in Gram negative opportunistic pathogens
  16. High-resolution in situ transcriptomics of Pseudomonas aeruginosa unveils genotype independent patho-phenotypes in cystic fibrosis lungs
  17. Mutations causing low level antibiotic resistance ensure bacterial survival in antibiotic-treated hosts
  18. The Small RNA ErsA of Pseudomonas aeruginosa Contributes to Biofilm Development and Motility through Post-transcriptional Modulation of AmrZ
  19. Cellulose production is coupled to sensing of the pyrimidine biosynthetic pathway via c-di-GMP production by the DgcQ protein of Escherichia coli
  20. Correction to: Rossi E, et al., “It’s a gut feeling” – Escherichia coli biofilm formation in the gastrointestinal tract environment
  21. “It’s a gut feeling” – Escherichia coli biofilm formation in the gastrointestinal tract environment
  22. Interplay of the modified nucleotide phosphoadenosine 5′-phosphosulfate (PAPS) with global regulatory proteins in Escherichia coli: modulation of cyclic AMP (cAMP)-dependent gene expression and interaction with the HupA regulatory protein
  23. Glucose availability enhances lipopolysaccharide production and immunogenicity in the opportunistic pathogen Acinetobacter baumannii
  24. Exposure of E. coli to DNA-Methylating Agents Impairs Biofilm Formation and Invasion of Eukaryotic Cells via Down Regulation of the N-Acetylneuraminate Lyase NanA
  25. Characterization of the Escherichia coli σS core regulon by Chromatin Immunoprecipitation-sequencing (ChIP-seq) analysis
  26. Sulfate assimilation pathway intermediate phosphoadenosine 5'-phosphosulfate acts as a signal molecule affecting production of curli fibres in Escherichia coli
  27. Gene and Protein Expression in Response to Different Growth Temperatures and Oxygen Availability in Burkholderia thailandensis
  28. The immunosuppressive drug azathioprine inhibits biosynthesis of the bacterial signal molecule cyclic-di-GMP by interfering with intracellular nucleotide pool availability
  29. An efficient rRNA removal method for RNA sequencing in GC-rich bacteria
  30. The Pyrimidine Nucleotide Biosynthetic Pathway Modulates Production of Biofilm Determinants in Escherichia coli